Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.

from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992;116:881–887. 34. Durstine JL, Grandjean PW, Cox CA, Thompson PD. Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil 2002;22:385–398. 35. Theobald H, Bygren LO, Carstensen J, Engfeldt P. A moderate intake of wine is associated with reduced total mortality and reduced mortality from cardiovascular disease. J Stud Alcohol 2000;61:652–656. 36. Wannamethee SG, Shaper AG. Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health 1999;89:685–690. 37. Gronbaek M. Factors influencing the relation between alcohol and mortality – with focus on wine. J Intern Med 2001;250:291–308. 38. Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jensen G, Sorensen TI. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133:411–419. 39. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999;46:354–357. 40. Andersen LB, Schnohr P, Schroll M, Hein HO. All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med 2000;160:1621–1628. 41. Lissner L, Bengtsson C, Bjorkelund C, Wedel H. Physical activity levels and changes in relation to longevity. A prospective study of Swedish women. Am J Epidemiol 1996;143:54–62. 42. Saltin B. Physiological effects of physical conditioning. In: Hansen AT, Schnohr P, Rose G, ed. Ischaemic Heart Disease: the Strategy of Postponement. Chicago, IL: Year Book Medical Publishers; 1977. p104–115. 43. Wannamethee G, Shaper AG. Men who do not drink – a report from the British-Regional-Heart-Study. Int J Epidemiol 1988;17: 307–316.